Daniela Sousa

Daniela Sousa

Auto-generated profile, based on publicly available information

Daniela Sousa

Centre for Medically Assisted Procreation/Public Gamete Bank, Gynecology Department, Centro Materno-Infantil do Norte Dr. Albino Aroso (CMIN), Centro Hospitalar Universitário de Santo António (CHUdSA), Unidade Local de Saúde de Santo António (ULSSA), Porto, Portugal

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2025 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
EVEmídio Vale-Fernandes
Emídio Vale-Fernandes
MMMafalda V. Moreira
Mafalda V. Moreira
RBRaquel L. Bernardino
Raquel L. Bernardino
DSDaniela Sousa
Daniela Sousa
RBRaquel Brandão
Raquel Brandão
MMMariana Monteiro
Mariana Monteiro
Polycystic ovary syndrome (PCOS) and obesity can both disrupt reproductive function. However, the extent to which obesity contributes to PCOS manifestations is not very clear. This study aimed to disentangle the relative contributions of PCOS and obesity for reproductive dysfunction in women undergoing in vitro fertilization (IVF). A total of 129 women undergoing IVF treatments were recruited. Women were allocated into four groups according to body mass index (BMI) and PCOS diagnosis: normal-weight controls (n = 33; 21.70 ± 1.85 kg/m²), overweight/obesity controls (n = 28; 28.35 ± 3.05 kg/m²), normal-weight PCOS (n = 31; 21.92 ± 1.95 kg/m²), and overweight/obesity PCOS (n = 37; 31.67 ± 5.03 kg/m²). Circulating levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), anti-Müllerian hormone (AMH), glucose and insulin were measured in all groups, while insulin resistance was assessed by the Homeostatic Model (HOMA-IR). Additionally, on the oocyte retrieval day, ∆4-androstenedione, testosterone, progesterone and sex hormone-binding globulin (SHBG), were measured in plasma and follicular fluid (FF). IVF outcomes evaluated included the number of oocytes retrieved, oocyte immaturity, as well as fertilization and blastocyst formation rates. A multivariate analysis was performed to determine the independent effects of PCOS and obesity for reproductive and metabolic parameters. Women with PCOS presented significantly higher AMH levels, LH: FSH ratio, and lower FF progesterone levels, confirming these as PCOS-specific signatures regardless of BMI. In contrast, women with overweight/obesity had lower plasma and FF SHBG levels and greater HOMA-IR, independently of PCOS. Furthermore, ∆4-androstenedione and testosterone levels in plasma and FF were significantly higher in women with PCOS and overweight/obesity as compared to normal-weight women with PCOS. Despite the higher oocyte retrieval rates in women with PCOS, no differences in oocyte immaturity, fertilization and blastocyst formation rates were observed. PCOS and obesity independently disrupt female reproductive function suggesting that features associated with each condition may differ. Furthermore, our study shows that obesity exacerbates hyperandrogenism in women with PCOS, highlighting a synergistic detrimental impact on female reproductive function.

4 April 2025 in Molecular and Cellular Endocrinology
Verified
Journal Article
Open access
EVEmídio Vale-Fernandes
Emídio Vale-Fernandes
David CarragetaDavid Carrageta
David Carrageta
MMMafalda V. Moreira
Mafalda V. Moreira
Bárbara Guerra-CarvalhoBárbara Guerra-Carvalho
Bárbara Guerra-Carvalho
Bárbara RodriguesBárbara Rodrigues
Bárbara Rodrigues
MMMariana Monteiro
Mariana Monteiro
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, yet the molecular mechanisms influencing its pathophysiology remain poorly defined. A comprehensive prospective case-control study was conducted to elucidate the follicular fluid (FF) hormone and metabolite profile in women with PCOS and its implications for oocyte maturation and fertilization. The study involved 40 age- and body mass index (BMI)-matched women undergoing in vitro fertilization (IVF), including 20 diagnosed with PCOS and 20 controls with infertility due to tubal or male factors. A distinctive hormone profile in the FF of women with PCOS was identified, characterized by significantly higher anti-Müllerian hormone (AMH) levels (24.90±17.61 vs. 16.68±17.67 pmol/L, p=0.0039) and lower progesterone (8253±4748 vs. 25362±10862 ng/mL, p<0.0001) and estradiol levels (388.23±210.58 vs. 651.48±390.79 ng/mL, p=0.0208) compared to normoovulatory controls. Moreover, a metabolite fingerprint associated with glycolytic and mitochondrial dysfunction was observed, as evidenced by lower lactate (4575.44±1507.76 vs. 5595.34±1073.32 μmol/L, p=0.0182) and formate (64.51±16.06 vs. 75.81±16.63 μmol/L, p=0.0351) levels and higher citrate levels (136.93±52.53 vs. 109.15±24.17 μmol/L, p=0.0409) in the FF of women with PCOS. These findings suggest that the molecular profile of the FF in women with PCOS is related to granulosa cell glycolytic and mitochondrial dysfunction, which can have a negative impact on oocyte fertilization potential. The study provides an integrative analysis of the FF hormone and metabolite profile in women with PCOS, offering insights into the molecular mechanisms underlying the reproductive dysfunctions associated with this condition.